We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Communiqué de presse : De nouveaux résultats de phase II à 48 semaines relatifs au frexalimab confortent le potentiel d'efficacité élevée et durable dans le traitement de la sclérose en...
Sanofi: Information concerning the total number of voting rights and shares - March 2024 Information concerning the total number of voting rights and shares, provided pursuant to article L...
Sanofi - AGM 30.04.2024 - Availability of Preparatory documents COMBINED GENERAL MEETING OF APRIL 30, 2024 AVAILABILITY OF PREPARATORY DOCUMENTS The Company’s shareholders are invited to...
Sanofi - AGM 30.04.2024 - Mise à disposition des documents préparatoires ASSEMBLEE GENERALE MIXTE DU 30 AVRIL 2024 MODALITES DE MISE A DISPOSITION OU DE CONSULTATION DES DOCUMENTS...
Availability of the Q1 2024 Memorandum for modelling purposes Paris, France – March 22, 2024. Sanofi announced today that its Q1 2024 Memorandum for modelling purposes is available on the...
Sanofi: Information concerning the total number of voting rights and shares - February 2024 Information concerning the total number of voting rights and shares, provided pursuant to article...
Press Release: New Phase 2b results for amlitelimab support potential for best-in-class maintenance of response in atopic dermatitis New Phase 2b results for amlitelimab support potential for...
Communiqué de presse : De nouveaux résultats de phase II relatifs à l’amlitelimab confortent son potentiel de meilleur médicament de sa catégorie en termes de maintien de la réponse dans le...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.05 | 0.0575771533855 | 86.84 | 88.17 | 85.07 | 1336576 | 86.32358735 | DE |
4 | -0.78 | -0.889700011406 | 87.67 | 92.04 | 85.07 | 1364244 | 88.23650281 | DE |
12 | -4.78 | -5.21435584161 | 91.67 | 94.29 | 84.93 | 1356811 | 88.19436 | DE |
26 | -12.86 | -12.8922305764 | 99.75 | 101.16 | 80.6 | 1511822 | 88.29336023 | DE |
52 | -14.19 | -14.0383854373 | 101.08 | 105.18 | 80.6 | 1445966 | 93.38965953 | DE |
156 | 1.31 | 1.53073147932 | 85.58 | 106.66 | 76.45 | 1798585 | 91.11587518 | DE |
260 | 12.42 | 16.6778568551 | 74.47 | 106.66 | 67.65 | 2056337 | 87.25565152 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions